Hong Yeahwa, Shin Suji, Nasim Umar, Scala Helen M, Roberts Kalliope G, Potchernikov Alexander S, Woolley Brian E, Skoog David J, Bacchetta Matthew, Cook Keith E
Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA.
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Transplantation. 2025 Mar 1;109(3):467-475. doi: 10.1097/TP.0000000000005165. Epub 2024 Aug 20.
The pulmonary assist system (PAS) is a wearable respiratory support system that is currently under development for patients with chronic lung disease as a bridge to lung transplantation or as destination therapy. This study evaluates the long-term performance and biocompatibility of the PAS in a 5-d awake, ovine model.
The PAS was attached to normal sheep in venovenous configuration. Components of the PAS included a 0.9 m 2 surface area oxygenator and a lightweight, battery-powered axial flow pump. The system was also tested using the Abbott PediMag as the control pump. Each sheep was supported on the PAS for 5 d with 2 L/min blood flow and 4 L/min sweep gas. Activated clotting times of 200-240 s were maintained using intravenous heparin. Pump performance, oxygen transfer, oxygenator resistance, and hematologic parameters were measured throughout the support.
The PAS, either using the axial flow pump or PediMag (n = 4 each), was well tolerated by the sheep without signs of device-related organ damage or hemolysis. All the studies achieved the full, 5-d study duration. The oxygenator resistance remained consistent without significant clot formation in all experiments with an average resistance of 2.55 ± 0.10 mm Hg/(L/min). The system achieved an average oxygen transfer rate of 116.4 ± 5.5 mL/min, with an average Hb concentration of 9.2 ± 0.6 g/dL. White blood cell, platelet, and hematocrit levels also remained stable and within normal limits throughout the study period.
The PAS provided 5 d of uncomplicated ambulatory respiratory support with minimal clot formation, stable gas exchange, blood flow resistance, and hematologic parameters.
肺辅助系统(PAS)是一种可穿戴的呼吸支持系统,目前正在为慢性肺病患者开发,作为肺移植的桥梁或终末期治疗手段。本研究在5天清醒的绵羊模型中评估了PAS的长期性能和生物相容性。
将PAS以静脉-静脉配置连接到正常绵羊身上。PAS的组件包括一个表面积为0.9平方米的氧合器和一个轻便的、电池供电的轴流泵。该系统还使用雅培PediMag作为对照泵进行了测试。每只绵羊以2升/分钟的血流量和4升/分钟的吹扫气体在PAS上支持5天。使用静脉注射肝素维持活化凝血时间在200 - 240秒。在整个支持过程中测量泵性能、氧传递、氧合器阻力和血液学参数。
使用轴流泵或PediMag的PAS(每组n = 4),绵羊耐受性良好,没有与设备相关的器官损伤或溶血迹象。所有研究都达到了完整的5天研究时长。在所有实验中,氧合器阻力保持一致,没有明显的凝块形成,平均阻力为2.55±0.10毫米汞柱/(升/分钟)。该系统的平均氧传递率为116.4±5.5毫升/分钟,平均血红蛋白浓度为9.2±0.6克/分升。在整个研究期间,白细胞、血小板和血细胞比容水平也保持稳定且在正常范围内。
PAS提供了5天的无并发症的门诊呼吸支持,凝块形成最少,气体交换、血流阻力和血液学参数稳定。